Skip to content
healthcare.dev

Rivastigmine

NDC 70710-1198, Rivastigmine, patch, extended release, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1198
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206318
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1198 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE13.3 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
70710-1198-77071011980730 POUCH in 1 CARTON (70710-1198-7) / 24 h in 1 POUCH (70710-1198-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64dad603-2389-456b-8c18-d1d40b7e7419
  • NADAC price for package 70710119807

    GET /v1/drugs/nadac/70710119807

Use it

Look up 70710-1198 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1198 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1198. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.